Brief: Newron FY Net Loss At EUR 21.0 Mln

Newron Pharmaceuticals SpA

16/03/2021 06:06

March 16 (Reuters) - NEWRON PHARMACEUTICALS SPA  NWRN.S :
    * NEWRON ANNOUNCES 2020 FINANCIAL RESULTS AND PROVIDES
OUTLOOK FOR
2021
    * IN 2020, NEWRON REPORTED A NET LOSS OF EUR 21.0 MILLION,
COMPARED TO EUR 20.2 MILLION IN 2019
    * FY CASH USED IN OPERATING ACTIVITIES HAS BEEN REDUCED TO
EUR
15.6 MILLION FROM EUR 22.0 MILLION IN 2019
    * FY NEWRON'S NET RESEARCH AND DEVELOPMENT EXPENSES HAVE
SEEN A
REDUCTION TO EUR 14.9 MILLION FROM EUR 17.4 MILLION IN 2019
    * CASH AND OTHER CURRENT FINANCIAL ASSETS AT DECEMBER 31,
2020,
WERE AT EUR 31.3 MILLION, COMPARED TO EUR 39.2 MILLION AT
BEGINNING OF YEAR.

Source text for Eikon:  ID:nEQbcpcjda 
Further company coverage:  NWRN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))